Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials
Rubino DM, Pedersen SD, Connery L, et al.
Diabetes Obes Metab. Pub. online 9 Jan 2025.
Leggi